Alpha-1-antitrypsin in human brain tumors.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Journal of Neurosurgery

• Publication date

  1987-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3171/JNS.1987.67.2.0258PMID 3496430
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antifibrinolytic therapy of experimentally grown malignant brain tumors.

  1986cited by this paper
• The role of α1-antitrypsin deficiency in the pathogenesis of immune disorders

  1985cited by this paper
• The role of alpha 1-antitrypsin deficiency in the pathogenesis of immune disorders.

  1985cited by this paper
• Brain tumors and plasmin inhibitors.

  1984cited by this paper
• Protease inhibitors as anticarcinogens.

  1984cited by this paper
• The role of proteinase in cellular invasiveness

  1983cited by this paper
• Cerebral edema associated with meningiomas.

  1983cited by this paper
• Degradation of the subendothelial matrix by tumor cells.

  1983cited by this paper
• Human plasma proteinase inhibitors.

  1983cited by this paper
• The role of proteinases in cellular invasiveness.

  1983cited by this paper
• Modulation of the immune response by plasma protease inhibitors. I. Alpha 2-macroglobulin and alpha 1-antitrypsin inhibit natural killing and antibody-dependent cell-mediated cytotoxicity.

  1982cited by this paper
• Morphological identification of alpha‐I‐antitrypsin in the human small intestine

  1982cited by this paper
• Modulation of the Immune Response by Plasma Protease Inhibitors

  1982cited by this paper
• Clear Cell (Mesonephroid) Tumors of the Ovary with Characteristics Resembling Endodermal Sinus Tumor

  1982cited by this paper
• In vitro degradation of radiolabelled, intact basement membrane mediated by cellular plasminogen activator.

  1982cited by this paper
• Structure and variation of human α1–antitrypsin

  1982cited by this paper
• Alpha‐1‐antitrypsin immunoreactivity in gastric carcinoid

  1982cited by this paper
• Thrombin inhibition by malignant and normal cells: A cell‐bound antithrombin effect

  1981cited by this paper
• Lysosomal cathepsin B: correlation with metastatic potential.

  1981cited by this paper
• Lysosomal cathepsin B-like activity: mobilization in prereplicative and neoplastic epithelial cells

  1981cited by this paper
• Inhibition of human natural cytotoxicity by macromolecular antiproteases.

  1981cited by this paper
• Alpha‐1‐antitrypsin in a malignant mixed mesodermal tumor of the ovary

  1981cited by this paper
• Destruction of extracellular matrices containing glycoproteins, elastin, and collagen by metastatic human tumor cells.

  1980cited by this paper
• The mechanism of cell-mediated cytotoxicity. I. Killing by murine cytotoxic T lymphocytes requires cell surface thiols and activated proteases.

  1980cited by this paper
• Preferential digestion of basement membrane collagen by an enzyme derived from a metastatic murine tumor.

  1979cited by this paper
• A timekeeping enzyme in the pineal gland.

  1979cited by this paper
• Protease inhibitors antagonize the activation of polymorphonuclear leukocyte oxygen consumption.

  1979cited by this paper
• Demonstration of alpha 1-antitrypsin in hepatomas.

  1979cited by this paper
• Mammary plasminogen activator: correlation with involution, hormonal modulation and comparison between normal and neoplastic tissue.

  1979cited by this paper
• Cancer metastasis.

  1979cited by this paper
• Intracellular localization of human plasma proteins revealed by peroxidase-labeled antibody method in human tumors transplanted in nude mice.

  1979cited by this paper
• The concentration of alpha-1-antitrypsin in cerebrospinal fluid and serum in a series of 40 intracranial tumors.

  1979cited by this paper
• Immunohistochemical demonstration of alpha-1-antitrypsin in the islet cells of human pancreas

  1978cited by this paper
• Differences in secretion of the proteinase cathepsin B at the edges of human breast carcinomas and fibroadenomas

  1978cited by this paper
• Plasma protein production by human tumors xenotransplanted in nude mice.

  1978cited by this paper
• In vitro plasminogen activator activity in human brain tumors.

  1978cited by this paper
• Conditions which affect initiation of animal cell division by trypsin and thrombin

  1978cited by this paper
• Properties of isolated human alpha1-antitrypsins of Pi types M, S and Z.

  1978cited by this paper
• Isolation of a protease inhibitor from tissues resistant to tumor invasion.

  1977cited by this paper
• Association of a protease (plasminogen activator) with a specific membrane fraction isolated from transformed cells

  1976cited by this paper
• Comparison of the chemical, physical, and survival properties of normal and Z-variant alpha-1-antitrypsins.

  1976cited by this paper
• Techniques for inhibiting tumor metastases

  1975cited by this paper
• Fluorescent antibody studies of alpha-1-antitrypsin in adult human lung.

  1975cited by this paper
• Adjuvant therapy of cancer via the cellular immune mechanism or fibrin by induced fibrinolysis and oral anticoagulants

  1975cited by this paper
• Fibrinolysis associated with oncogenic transformation. Partial purification and characterization of the cell factor, a plasminogen activator.

  1974cited by this paper
• The inhibition of human plasmin by human antithrombin-heparin cofactor.

  1974cited by this paper
• SECRETION OF PLASMINOGEN ACTIVATOR BY STIMULATED MACROPHAGES

  1974cited by this paper
• AN ENZYMATIC FUNCTION ASSOCIATED WITH TRANSFORMATION OF FIBROBLASTS BY ONCOGENIC VIRUSES

  1973cited by this paper
• Increasing the efficiency of cancer chemotherapy with heparin: “Clinical study”

  1973cited by this paper
• AN ENZYMATIC FUNCTION ASSOCIATED WITH TRANSFORMATION OF FIBROBLASTS BY ONCOGENIC VIRUSES

  1973cited by this paper
• FIBRINOLYSIS ASSOCIATED WITH ONCOGENIC TRANSFORMATION

  1973cited by this paper
• Local vascular changes induced by the cocarcinogen, phorbol myristate acetate.

  1970cited by this paper
• Reduced Incidence of Spontaneous Metastases with Long‐Term Coumadin* Therapy

  1968cited by this paper
• Tissue activators of plasminogen.

  1966cited by this paper
• Alterations in fibrinogen, plasminogen, and inhibitors of plasmin with the growth of V2 carcinoma in rabbits.

  1965cited by this paper
• Anticoagulants and the development of pulmonary metastases. Anticoagulant effect on the Walker 256 carcinosarcoma in rats.

  1962cited by this paper
• Diffusion-in-gel methods for immunological analysis.

  1958cited by this paper

• Prognostic Value of SERPINA1 as a Biomarker for Poor Survival of Gliomas

  2025cites this paper
• Evaluation of the diagnostic performance of Alpha-1-Antitrypsin in early detection of hepatocellular carcinoma.

  2023cites this paper
• Digital Polymerase Chain Reaction Quantification of SERPINA1 Predicts Prognosis in High-Grade Glioma.

  2018cites this paper
• Subventricular zone involvement in Glioblastoma – A proteomic evaluation and clinicoradiological correlation

  2017cites this paper
• Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis

  2017cites this paper
• Serum concentration of alpha-1 antitrypsin is significantly higher in colorectal cancer patients than in healthy controls

  2014cites this paper
• Serum peptide pattern that differentially diagnoses hepatitis B virus‐related hepatocellular carcinoma from liver cirrhosis

  2014cites this paper
• Biomarkers identification in fibromyalgia syndrome

  2013cites this paper
• Structural Features, Biological Functions of the Alpha-1 Antitrypsin and Contribution to Esophageal Cancer

  2012cites this paper
• Alpha-1-Antitrypsin in Pathogenesis of Hepatocellular Carcinoma

  2012cites this paper
• Identification of Potential Glycoprotein Biomarkers in Estrogen Receptor Positive (ER+) and Negative (ER-) Human Breast Cancer Tissues by LC-LTQ/FT-ICR Mass Spectrometry

  2012cites this paper
• A unique proteolytic fragment of alpha1-antitrypsin is elevated in ductal fluid of breast cancer patient

  2010cites this paper
• Alpha-1 Antitrypsin Deficient Squamous Cell Carcinoma of Esophagus in the Azeri Population of Iran Correlation of Genotype With Phenotype and Survival

  2010cites this paper
• Anaplastic pleomorphic xanthoastrocytoma

  2009cites this paper
• Advances in Brief Elevated Levels of Mr 92 , 000 Type IV Collagenase in Human Brain Tumors 1

  2006cites this paper
• Gerinnungsstörungen bei neurochirurgischen Tumorpatienten

  2006cites this paper
• Synthesis and secretion of α2-macroglobulin by human glioma established cell lines

  2005cites this paper
• Thromboembolic complications associated with brain tumors

  2005influential citation
• Histopathological features of recurrent pleomorphic xanthoastrocytomas: further corroboration of the glial nature of this neoplasm

  2004cites this paper
• Increased plasma levels of serine proteinase inhibitors in lung cancer patients.

  2004cites this paper
• The challenges in translating present knowledge of the molecular biology of breast cancer into clinical use

  2004cites this paper
• Multiple effects of &agr;1-antitrypsin on breast carcinoma MDA-MB 468 cell growth and invasiveness

  2003cites this paper
• Expression of macrophage/histiocytic antigens in pleomorphic xanthoastrocytomas.

  2003cites this paper
• Effects of native and cleaved forms of alpha1-antitrypsin on ME 1477 tumor cell functional activity.

  2002cites this paper
• Multi-agent cytostatic treatment of ‘low-grade’ gliomas

  2000cites this paper
• Production of amyloid beta protein precursor as a proteinase inhibitor by human astrocytic tumors.

  1999cites this paper
• Profiles of Plasma Serpins in Patients with Advanced Malignant Melanoma, Gastric Cancer and Breast Cancer

  1998cites this paper
• Cytostatic Agents in the Management of Malignant Gliomas.

  1998cites this paper
• Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors.

  1994cites this paper
• Lobar pilocytic astrocytomas of the cerebral hemispheres: II. Pathobiology--morphogenesis of the eosinophilic granular bodies.

  1994cites this paper
• Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors.

  1993cites this paper
• Breast cancer patients--the support given by nurses.

  1993cites this paper
• Elevated Levels of Mr 92,000 Type IV Collagenase in Human Brain Tumors

  1993cites this paper
• Synthesis and secretion of alpha 2-macroglobulin by human glioma established cell lines.

  1992cites this paper
• An evaluation of the prognostic significance of alpha-1-antitrypsin expression in adenocarcinomas of the lung: an immunohistochemical analysis.

  1992cites this paper
• Plasma Fibrinolytic Profile in Patients with Brain Tumors

  1991cites this paper
• Alpha-1-antichymotrypsin in human glioblastoma multiforme cells and its relation to GFAP immunostaining.

  1991cites this paper
• Serpins and Brain Tumors: Roles in Pathogenesis

  1990cites this paper
• Metabolism of the Malignant Astrocytoma

  1990cites this paper
• Presence and Significance of α1-Antitrypsin in Human Brain Tumors

  1990cites this paper
• Serpin inhibitors of urokinase and thrombin in normal rat brain and the 9L brain tumor: evidence for elevated expression of protease nexin I-like inhibitor and a novel sodium dodecyl sulfate-activated tumor antithrombin.

  1990cites this paper
• Immunobiology of brain tumors.

  1990cites this paper
• New human colorectal carcinoma cell lines that secrete proteinase inhibitors in vitro

  1989cites this paper
• Immunohistochemical demonstration of alpha‐1‐proteinase inhibitor in brain tumors

  1987cites this paper